Matthias Schwab is professor and chair of Clinical Pharmacology, and heads the department of Clinical Pharmacology, University of Tuebingen and the Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. He studied medicine, holds board certifications in Pediatrics and Clinical Pharmacology. He was visiting professor at St Jude Children’s Res. Hosp., Memphis, US. Schwab’s scientific interests focus on personalized medicine and pharmacogenomics (PGx) and the contribution of ADME genes for better understanding of drug response. Special interests lies in the application of Omics-technologies (e.g. genomics, epigenomics, metabonomics). He is involved in programs for the clinical implementation of research findings and acts as principle investigator of academically initiated drug trials. Schwab received numerous awards, and is member of the German National Academy of Sciences Leopoldina, the Academy of Sciences and Literature, Mainz, Germany, and the Academia Europaea. His scientific accomplishments result in > 400 peer reviewed publications and he serves as Editor-in-Chief of Pharmacogenetics & Genomics, Drug Research, and as Section Editor of Genome Medicine.
Title : Pharmacogenomics: current status and future directions